These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 8116236)

  • 21. [Construction and immunogenicity of recombinant Canine adenovirus type 2 with the external part of glycoprotein of rabies virus].
    Wang YZ; Zhang SF; Hu RL; Wang X; Xiao YQ
    Wei Sheng Wu Xue Bao; 2005 Apr; 45(2):213-7. PubMed ID: 15989263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new rabies vaccine based on a recombinant ORF virus (parapoxvirus) expressing the rabies virus glycoprotein.
    Amann R; Rohde J; Wulle U; Conlee D; Raue R; Martinon O; Rziha HJ
    J Virol; 2013 Feb; 87(3):1618-30. PubMed ID: 23175365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanogram quantities of plasmid DNA encoding the rabies virus glycoprotein protect mice against lethal rabies virus infection.
    Ray NB; Ewalt LC; Lodmell DL
    Vaccine; 1997 Jun; 15(8):892-5. PubMed ID: 9234541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of passive immunization or maternally transferred immunity on the antibody response to a genetic vaccine to rabies virus.
    Wang Y; Xiang Z; Pasquini S; Ertl HC
    J Virol; 1998 Mar; 72(3):1790-6. PubMed ID: 9499029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA vaccine for rabies: relevance of the trans-membrane domain of the glycoprotein in generating an antibody response.
    Rath A; Choudhury S; Batra D; Kapre SV; Rupprecht CE; Gupta SK
    Virus Res; 2005 Nov; 113(2):143-52. PubMed ID: 15978691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rabies DNA vaccine encoding lysosome-targeted glycoprotein supplemented with Emulsigen-D confers complete protection in preexposure and postexposure studies in BALB/c mice.
    Kaur M; Saxena A; Rai A; Bhatnagar R
    FASEB J; 2010 Jan; 24(1):173-83. PubMed ID: 19741168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A chimpanzee-origin adenovirus vector expressing the rabies virus glycoprotein as an oral vaccine against inhalation infection with rabies virus.
    Zhou D; Cun A; Li Y; Xiang Z; Ertl HC
    Mol Ther; 2006 Nov; 14(5):662-72. PubMed ID: 16797238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancing comparative rabies DNA vaccine effectiveness through glycoprotein gene modifications.
    Osinubi MO; Wu X; Franka R; Niezgoda M; Nok AJ; Ogunkoya AB; Rupprecht CE
    Vaccine; 2009 Nov; 27(51):7214-8. PubMed ID: 19925956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycoprotein from street rabies virus BD06 induces early and robust immune responses when expressed from a non-replicative adenovirus recombinant.
    Wang S; Sun C; Zhang S; Zhang X; Liu Y; Wang Y; Zhang F; Wu X; Hu R
    Arch Virol; 2015 Sep; 160(9):2315-23. PubMed ID: 26143474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A synthetic peptide encompassing the G5 antigenic region of the rabies virus induces high avidity but poorly neutralizing antibody in immunized animals.
    Niederhäuser S; Bruegger D; Zahno ML; Vogt HR; Peterhans E; Zanoni R; Bertoni G
    Vaccine; 2008 Dec; 26(52):6749-53. PubMed ID: 18955098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of glycoprotein gene of the rabies virus 3aG strain by E-3 deleted adenovirus recombinant.
    Zhang X; Zhang Y; Li W
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Sep; 14(3):281-4. PubMed ID: 11498699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of rabies virus glycoprotein gene into eukaryotic system and determination of potential T-cell epitopes.
    Tomar NR; Chandra R; Kumar R; Tiwari AK; Kumar A
    Indian J Exp Biol; 2011 Aug; 49(8):594-9. PubMed ID: 21870427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of combined vaccines for rabies and immunocontraception.
    Wu X; Franka R; Svoboda P; Pohl J; Rupprecht CE
    Vaccine; 2009 Nov; 27(51):7202-9. PubMed ID: 19925954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune effector mechanisms required for protection to rabies virus.
    Xiang ZQ; Knowles BB; McCarrick JW; Ertl HC
    Virology; 1995 Dec; 214(2):398-404. PubMed ID: 8553540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene.
    Cenna J; Tan GS; Papaneri AB; Dietzschold B; Schnell MJ; McGettigan JP
    Vaccine; 2008 Nov; 26(50):6405-14. PubMed ID: 18804506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the immunogenicity of two inactivated recombinant rabies viruses overexpressing the glycoprotein.
    Navid MT; Li Y; Zhou M; Cui M; Fu ZF; Tang L; Zhao L
    Arch Virol; 2016 Oct; 161(10):2863-70. PubMed ID: 27438075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product.
    Xiang Z; Gao G; Reyes-Sandoval A; Cohen CJ; Li Y; Bergelson JM; Wilson JM; Ertl HC
    J Virol; 2002 Mar; 76(6):2667-75. PubMed ID: 11861833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenic and antigenic properties of recombinant soluble glycoprotein of rabies virus.
    Gupta PK; Sharma S; Walunj SS; Chaturvedi VK; Raut AA; Patial S; Rai A; Pandey KD; Saini M
    Vet Microbiol; 2005 Jul; 108(3-4):207-14. PubMed ID: 15916870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rabies-virus-glycoprotein-pseudotyped recombinant baculovirus vaccine confers complete protection against lethal rabies virus challenge in a mouse model.
    Wu Q; Yu F; Xu J; Li Y; Chen H; Xiao S; Fu ZF; Fang L
    Vet Microbiol; 2014 Jun; 171(1-2):93-101. PubMed ID: 24793501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of a protective immune response to rabies virus in sheep after oral immunization with transgenic maize, expressing the rabies virus glycoprotein.
    Loza-Rubio E; Rojas-Anaya E; López J; Olivera-Flores MT; Gómez-Lim M; Tapia-Pérez G
    Vaccine; 2012 Aug; 30(37):5551-6. PubMed ID: 22749836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.